SpyGlass Pharma, Inc. (SGP) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$21.97M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$15.41M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$9.30M; Depreciation and amortization (m).
- 2025-03-31: Basis Reported; EBITDA (m); Operating income -$7.42M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | -$21.97M | (m) | (m) | (m) | $1.93M* | -$14.84M* | (m) | $10.94M | (m) | $0.00 |
| 2026-03-31 | Reported | (m) | -$15.41M | (m) | (m) | (m) | $676.00K | -$13.54M | (m) | $8.54M | (m) | $0.00 |
| 2025-06-30 | Reported | (m) | -$9.30M | (m) | (m) | (m) | $52.00K* | -$6.33M* | (m) | $7.33M | (m) | $0.00 |
| 2025-03-31 | Reported | (m) | -$7.42M | (m) | (m) | (m) | $164.00K | -$8.20M | (m) | $6.05M | (m) | $0.00 |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$41.45M | (m) | (m) | (m) | $789.00K | -$32.70M | (m) | $29.18M | (m) | $0.00 |
| 2024-12-31 | Reported | (m) | -$27.06M | (m) | (m) | (m) | $1.99M | -$22.03M | (m) | $19.98M | (m) | $0.00 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |